Oryx International Growth Fund releases unaudited half-year results to September 2025. The RNS is a notice; investors must read the full report for NAV, performance & outlook.
This article covers information on Oryx International Growth Fund Ld.
LON:OIGOryx International Growth Fund Limited has released its Unaudited Condensed Half-Yearly Results for the six months ended 30 September 2025. Today’s RNS is a formal notice that the report is out rather than a summary of the numbers, so investors will need to read the full document to see performance, portfolio moves, and any commentary from the Board or Manager.
The report will shortly be available on the Company’s website and is already accessible via the London Stock Exchange PDF link provided in the announcement.
The Board confirmed publication of the half-year report covering the period to 30 September 2025. The announcement does not include any financial figures, changes to strategy, buyback activity, dividend decisions, or portfolio details. It is strictly a release notice.
Key administrative details are provided, including the Company Secretary contact at BNP Paribas S.A., Guernsey Branch.
You can access the documents here:
Half-year results are one of the most important checkpoints for an investment company. They usually contain the net asset value (NAV) per share, total return for the period, a review of portfolio activity, and the Manager’s outlook. For listed investment trusts and funds, these updates can influence the discount or premium to NAV as the market digests fresh information.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
65 viewsLikes
No ratings yet
Last updated:
Because today’s RNS does not disclose any numbers, the market reaction will depend on what the full report shows. If the NAV performance, balance sheet and outlook are better than expected, the discount could narrow. If costs are higher, or holdings have struggled, the discount could widen.
When you open the PDF, here is a quick checklist to help you cut through the noise:
Without the figures in the RNS itself, here are the levers that typically move an investment company’s share price around a half-year update:
To be clear, today’s RNS is just the release notice. It did not include:
All of the above, if provided, will be in the attached PDF and on the Company’s website once posted.
| Company | Oryx International Growth Fund Limited |
| Period covered | Six months ended 30 September 2025 |
| Report type | Condensed Half-Yearly Results |
| Audit status | Unaudited |
| Publication date | 10 December 2025 |
| PDF link | RNS PDF – Half-Yearly Results |
| Company website | www.oryxinternationalgrowthfund.co.uk |
| Company Secretary | BNP Paribas S.A., Guernsey Branch |
| Enquiries | 01481 750850 |
This is a straightforward housekeeping RNS: the results are out, but the market needs to read them to judge performance and positioning. I would call today’s news neutral in isolation.
What would shift that view? Positive surprises on NAV progress, disciplined costs, and a confident outlook would be constructive. Conversely, disappointing NAV development, higher charges, or cautious guidance could weigh on sentiment. The real substance is in the PDF – worth a careful read.
As ever, price moves around result days often reflect changes in expectations as much as the numbers themselves. The detail will decide whether the discount to NAV tightens, widens, or stays put.
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.